+30.4%
GSK vs HDB
-34.6%
+65.0%
-18.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | HDB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.9% | -0.4% | -1.5% | -1.8% |
| 7D | -1.8% | +0.4% | -2.3% | -1.9% |
| 30D | -2.2% | -2.8% | +0.6% | -1.5% |
| 3M | -1.8% | -3.5% | +1.7% | -1.3% |
| 6M | -10.6% | -24.7% | +14.1% | -4.1% |
| YTD | +4.4% | -36.6% | +41.0% | +14.5% |
| 1Y | +30.4% | -34.4% | +64.8% | +43.9% |
| All | +30.4% | -34.6% | +65.0% | +43.9% |
Cumulative growth
Daily Returns
Daily percentage return beside HDB.
Daily Out/Under-Performance
Portfolio return minus HDB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × HDB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded HDB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling